Newable Ventures Limited (NVL) are pleased to announce a re-investment in the cell transportation company Atelerix.
By jesse_orange
Atelerix’s products are used for the storage and transportation of human cells and tissues at room temperature, removing the risk for cell degradation or damage. NVL’s investment in the company coincides with an extremely challenging time for the UK economy, which is expected to enter recession as a result of the Covid-19 pandemic. Despite this … Continued